Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000932440-07-000110
Filing Date
2007-02-14
Accepted
2007-02-14 10:17:44
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A sch13g_1137063.txt SC 13G/A 16920
2 EXHIBIT 99.1 exh99-1_1104122.txt EX-99 2110
  Complete submission text file 0000932440-07-000110.txt   21085
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-37954 | Film No.: 07614402
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022
Business Address 430 PARK AVENUE 12TH FLOOR NEW YORK NY 10022 212-624-2567
Ridgeback Capital Investments Ltd. (Filed by) CIK: 0001358916 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A